• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression.

作者信息

Bordeleau François, Brownell David, Chabaud Stephane, Huot Marc-Etienne, Bolduc Stephane

机构信息

CHU de Québec-Université Laval Research Center (Oncology Division) and Université Laval Cancer Research Center, Quebec City, QC, Canada.

Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Quebec City, QC, Canada.

出版信息

Stem Cell Investig. 2023 Mar 7;10:5. doi: 10.21037/sci-2023-004. eCollection 2023.

DOI:10.21037/sci-2023-004
PMID:36909249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995704/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8f6/9995704/47f4f850cf51/sci-10-2023-004-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8f6/9995704/47f4f850cf51/sci-10-2023-004-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8f6/9995704/47f4f850cf51/sci-10-2023-004-f1.jpg

相似文献

1
Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression.重建膀胱癌微环境的异质性以研究其复发和进展。
Stem Cell Investig. 2023 Mar 7;10:5. doi: 10.21037/sci-2023-004. eCollection 2023.
2
Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.成纤维细胞雌激素受体α通过增加肿瘤微环境中的CCL1和IL-6信号促进膀胱癌侵袭。
Am J Cancer Res. 2015 Feb 15;5(3):1146-57. eCollection 2015.
3
Tumor-associated Macrophages Facilitate Bladder Cancer Progression by Increasing Cell Growth, Migration, Invasion and Cytokine Expression.肿瘤相关巨噬细胞通过增加细胞生长、迁移、侵袭和细胞因子表达促进膀胱癌进展。
Anticancer Res. 2020 May;40(5):2715-2724. doi: 10.21873/anticanres.14243.
4
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.膀胱癌微环境中与预后相关基因的鉴定——基于 TCGA 数据库。
Biomed Res Int. 2020 Nov 3;2020:9143695. doi: 10.1155/2020/9143695. eCollection 2020.
5
Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.神经钙黏蛋白 4 是膀胱癌的一种预后生物标志物，与免疫浸润相关。
Bioengineered. 2022 May;13(5):13986-13999. doi: 10.1080/21655979.2022.2085284.
6
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.整合分析揭示了一种基于炎症性癌症相关成纤维细胞的亚型，这对预测膀胱癌患者的预后和免疫治疗反应具有重要意义。
Int J Mol Sci. 2022 Dec 15;23(24):15970. doi: 10.3390/ijms232415970.
7
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.Tenascin-C 促进膀胱癌的进展，其作用依赖于 syndecan-4，并涉及 NF-κB 信号通路的激活。
BMC Cancer. 2022 Mar 4;22(1):240. doi: 10.1186/s12885-022-09285-x.
8
Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.基于癌症相关成纤维细胞景观和肿瘤微环境浸润特征的泛癌分析和分子亚型揭示了上皮性卵巢癌的临床结局和免疫治疗反应。
Front Immunol. 2022 Aug 10;13:956224. doi: 10.3389/fimmu.2022.956224. eCollection 2022.
9
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.FGFR3 突变激活可诱导管腔样乳头状膀胱肿瘤形成并偏向男性。
Eur Urol. 2023 Jan;83(1):70-81. doi: 10.1016/j.eururo.2022.09.030. Epub 2022 Oct 21.
10
Single-cell analysis reveals the COL11A1 fibroblasts are cancer-specific fibroblasts that promote tumor progression.单细胞分析显示，COL11A1成纤维细胞是促进肿瘤进展的癌症特异性成纤维细胞。
Front Pharmacol. 2023 Jan 20;14:1121586. doi: 10.3389/fphar.2023.1121586. eCollection 2023.

引用本文的文献

1
The role of cancer-associated fibroblasts in bladder cancer progression.癌症相关成纤维细胞在膀胱癌进展中的作用。
Heliyon. 2023 Sep 4;9(9):e19802. doi: 10.1016/j.heliyon.2023.e19802. eCollection 2023 Sep.

本文引用的文献

1
Single-cell sequencing technologies in bladder cancer research: Applications and challenges.膀胱癌研究中的单细胞测序技术：应用与挑战
Front Genet. 2022 Oct 19;13:1027909. doi: 10.3389/fgene.2022.1027909. eCollection 2022.
2
3D bioprinted cancer models: from basic biology to drug development.3D生物打印癌症模型：从基础生物学到药物开发
Nat Rev Cancer. 2022 Dec;22(12):679-692. doi: 10.1038/s41568-022-00514-w. Epub 2022 Oct 24.
3
The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
癌症相关成纤维细胞亚群的异质性：它们的起源、生物标志物及其在肿瘤微环境中的作用。
Cancer Sci. 2023 Jan;114(1):16-24. doi: 10.1111/cas.15609. Epub 2022 Oct 19.
4
Cancer-Associated Fibroblasts in a 3D Engineered Tissue Model Induce Tumor-like Matrix Stiffening and EMT Transition.三维工程组织模型中的癌症相关成纤维细胞诱导肿瘤样基质硬化和上皮-间质转化
Cancers (Basel). 2022 Aug 5;14(15):3810. doi: 10.3390/cancers14153810.
5
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin.三阴性乳腺癌转移涉及复杂的上皮-间充质转化动态，需要波形蛋白。
Sci Transl Med. 2022 Aug 3;14(656):eabn7571. doi: 10.1126/scitranslmed.abn7571.
6
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.表型异质性由中间 EMT 状态的可塑性驱动，控制着乳腺癌的疾病进展和转移。
Sci Adv. 2022 Aug 5;8(31):eabj8002. doi: 10.1126/sciadv.abj8002. Epub 2022 Aug 3.
7
BCG in Bladder Cancer Immunotherapy.卡介苗在膀胱癌免疫治疗中的应用
Cancers (Basel). 2022 Jun 23;14(13):3073. doi: 10.3390/cancers14133073.
8
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.膀胱癌化疗改良的新兴策略：当前知识与未来展望。
J Adv Res. 2022 Jul;39:187-202. doi: 10.1016/j.jare.2021.11.010. Epub 2021 Nov 24.
9
Applications of Polymers for Organ-on-Chip Technology in Urology.聚合物在泌尿外科芯片器官技术中的应用
Polymers (Basel). 2022 Apr 20;14(9):1668. doi: 10.3390/polym14091668.
10
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.肿瘤生物学和药物测试中患者来源的膀胱癌类器官模型：一项系统综述
Cancers (Basel). 2022 Apr 20;14(9):2062. doi: 10.3390/cancers14092062.